The Rotation of Disinfectants Principle: True or False? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Rotation of Disinfectants Principle: True or False?
The author defines sanitizers, disinfectants, and antibiotics, and examines the question of whether the rotation of disinfectants is scientifically warranted.


Pharmaceutical Technology
Volume 33, Issue 2, pp. 58-71

103. H.E. Morton, "The Relationship of Concentration and Germicidal Efficiency of Ethyl Alcohol," Ann. N.Y Acad. Sci. 53, 191–196 (1950).

104. C.E. Coulthard and G. Sykes, "The Germicidal Effect of Alcohol with Special Reference to its Action on Bacterial Spores," Pharm. J. 137, 79–8l (1936).

105. C.R. Smith, "Alcohol as a Disinfectant against the Tubercle Bacillus," Public Health Report 62, 1285–1295 (1947).

106. J.M. Tennent et al., "Cloning and Expression of Staphylococcus aureus Plasmid-Mediated Quaternary Ammonium Resistance in Escherichia coli, " Antimicrob. Agents Chemother. 27 (1), 79–83 (1985).

107. M.S. To et al., "Postadaptational Resistance to Benzalkonium Chloride and Subsequent Physicochemical Modifications of Listeria monocytogenes, " Appl. Environ. Microbiol. 68 (11), 5258–5264 (2002).

108. M. Sondossi and H.W. Rossmoore, "Applications and Mode of Action of Formaldehyde Condensate Biocides," Adv. Appl. Microbiol. 33, 223–277 (1988).

109. M.S. Favero and W.W. Bond, "Chemical Disinfection of Medical and Surgical Materials,"in Disinfection, S.S. Block, Ed. (Lea and Febiger, Philadelphia, 4th ed., 1991), pp. 617–641.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here